ATE310527T1 - Lipide zur stimulierung der immunreaktion - Google Patents

Lipide zur stimulierung der immunreaktion

Info

Publication number
ATE310527T1
ATE310527T1 AT00990102T AT00990102T ATE310527T1 AT E310527 T1 ATE310527 T1 AT E310527T1 AT 00990102 T AT00990102 T AT 00990102T AT 00990102 T AT00990102 T AT 00990102T AT E310527 T1 ATE310527 T1 AT E310527T1
Authority
AT
Austria
Prior art keywords
lipids
immune response
esterified
glycerol
fatty acids
Prior art date
Application number
AT00990102T
Other languages
English (en)
Inventor
William Leslie Porter
Original Assignee
William Leslie Porter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10867185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE310527(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by William Leslie Porter filed Critical William Leslie Porter
Application granted granted Critical
Publication of ATE310527T1 publication Critical patent/ATE310527T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Optical Communication System (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00990102T 1999-12-29 2000-12-20 Lipide zur stimulierung der immunreaktion ATE310527T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930862.9A GB9930862D0 (en) 1999-12-29 1999-12-29 Immune response stimulation
PCT/GB2000/004890 WO2001049277A2 (en) 1999-12-29 2000-12-20 Immune response modulation

Publications (1)

Publication Number Publication Date
ATE310527T1 true ATE310527T1 (de) 2005-12-15

Family

ID=10867185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990102T ATE310527T1 (de) 1999-12-29 2000-12-20 Lipide zur stimulierung der immunreaktion

Country Status (7)

Country Link
US (1) US20020193576A1 (de)
EP (1) EP1282430B1 (de)
AT (1) ATE310527T1 (de)
AU (1) AU2689901A (de)
DE (1) DE60024326T2 (de)
GB (2) GB9930862D0 (de)
WO (1) WO2001049277A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049247A1 (en) 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
AU2001264079A1 (en) * 2000-06-14 2001-12-24 William Leslie Porter Lipids for modulating immune response
GB0315783D0 (en) * 2003-07-04 2003-08-13 Norferm Da Use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727834D0 (en) * 1987-11-27 1987-12-31 Imp Cancer Res Tech Process for producing antibodies
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation

Also Published As

Publication number Publication date
DE60024326T2 (de) 2006-08-17
US20020193576A1 (en) 2002-12-19
DE60024326D1 (de) 2005-12-29
WO2001049277A2 (en) 2001-07-12
GB9930862D0 (en) 2000-02-16
WO2001049277A3 (en) 2002-11-28
EP1282430A2 (de) 2003-02-12
EP1282430B1 (de) 2005-11-23
AU2689901A (en) 2001-07-16
GB0014438D0 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
ES2111535T3 (es) Procedimiento para la preparacion de esteres glicosidos y composiciones que comprenden esteres glicosidos.
AR027193A1 (es) Una formula mejorada para ninos, un hidrolizado de proteina para uso en tal formula para ninos, y un metodo para la produccion de tal hidrolizado
AR020884A1 (es) Genes de enzimas modificadoras de acidos grasos vegetales asociadas con la formacion de dobles enlaces
ES2046249T3 (es) Preparaciones aromatizadas con efecto antimicrobiano.
ES2103316T3 (es) Composiciones de limpieza.
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
EP0378936A3 (en) Use of salicylic-acid derivatives in the treatment of aging of the skin
MX9100229A (es) Composiciones alimenticias y farmaceuticas que contienen acidos grasos monoinsaturados de cadena corta,y metodos de uso
DK1233969T3 (da) Mono- og disaccharridderivater
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
ES2157898T3 (es) Aceites microbianos y usos de los mismos.
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
TR199801784T2 (en) Kuma� yumu�atma bile�i�i / bile�imi.
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
KR910000157A (ko) 흡수성이 개선된 비타민 e 조성물
BR0215303A (pt) Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol
BG102234A (en) Esters of iodized fatty acids, the iodized fatty acids and their derivatives produced by the the addition of hydrogen iodide in the application of alkylylated derivatives and alkaline iodides, and their pharmacological application
FI935051A0 (fi) Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser
ATE310527T1 (de) Lipide zur stimulierung der immunreaktion
DE60123603D1 (de) Lipide zur änderung des abwehrsystems
DE69000719D1 (de) Hautreinigungsmittel.
NO912890L (no) Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling.
ATE165213T1 (de) Mit morphogen angereicherte nahrungszusammenstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties